Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00912223 · ClinicalTrials.gov registry record · Phase 2
Blood Stem Cell Transplant With Low Dose Chemotherapy for Relapsed Follicular Non-Hodgkin's Lymphoma (BMT CTN 0701)
A Phase 2 study, sponsored by Medical College of Wisconsin.
- Completed
- Registry status
- Phase 2
- Development phase
- 65
- Enrollment target
NCT00912223 is a Phase 2 study that has completed, run by Medical College of Wisconsin. The registered enrollment target is 65 participants.
The verdict
NCT00912223, a Phase 2 study, has completed, sponsored by Medical College of Wisconsin.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 65 participants
- Enrollment target
Study Summary
Blood stem cell transplants are one treatment option for people with lymphoma or other types of blood cancers. For this type of treatment, family members or unrelated donors with a similar tissue type usually donate their blood stem cells to the transplant patients. This study will evaluate the effectiveness of a type of blood stem cell transplant that uses lower doses of chemotherapy in people with relapsed follicular non-Hodgkin's lymphoma (NHL).
Interventions
- BIOLOGICAL Hematopoietic Stem Cell Transplant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2009-04 |
| Est. Completion | 2016-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00912223
The ClinicalTrials.gov registry entry for NCT00912223 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical College of Wisconsin, which has 447 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Hematopoietic Stem Cell Transplant is the first listed.
NCT00912223 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00912223 about?
NCT00912223 is a clinical study titled "Blood Stem Cell Transplant With Low Dose Chemotherapy for Relapsed Follicular Non-Hodgkin's Lymphoma (BMT CTN 0701)". Blood stem cell transplants are one treatment option for people with lymphoma or other types of blood cancers. For this type of treatment, family members or unrelated donors with a similar tissue type usually donate their blood stem cells to the transplant patients. This study will evaluate the effe...
What is the current status of trial NCT00912223?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 65 participants. The study started on 2009-04. Estimated completion is 2016-08.
What interventions are being tested in trial NCT00912223?
The interventions under investigation include: Hematopoietic Stem Cell Transplant (BIOLOGICAL).
Who is sponsoring clinical trial NCT00912223?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.